Scarica l'app Stockscreener
36.47
9.84%
-3.98
Dopo l'orario di chiusura:
36.47
Precedente Chiudi:
$40.45
Aprire:
$40.06
Volume 24 ore:
2.48M
Relative Volume:
2.52
Capitalizzazione di mercato:
$4.11B
Reddito:
$14.09M
Utile/perdita netta:
$-176.94M
Rapporto P/E:
-16.96
EPS:
-2.15
Flusso di cassa netto:
$-141.24M
1 W Prestazione:
+10.50%
1M Prestazione:
+48.74%
6M Prestazione:
+127.51%
1 anno Prestazione:
+91.95%
Intervallo 1D:
$35.91
$40.54
Intervallo di 1 settimana:
$32.36
$41.47
Portata 52W:
$14.06
$41.47
Newamsterdam Pharma Company Nv Stock (NAMS) Company Profile
Nome
Newamsterdam Pharma Company Nv
Settore
Industria
Telefono
35 206 2971
Indirizzo
GOOIMEER 2-35, NARRDEN
Confronta NAMS con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
NAMS
Newamsterdam Pharma Company Nv
|
36.47 | 4.26B | 14.09M | -176.94M | -141.24M | -2.15 |
|
VRTX
Vertex Pharmaceuticals Inc
|
408.61 | 105.69B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
481.07 | 61.52B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
569.17 | 60.69B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
837.28 | 50.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
318.02 | 35.25B | 4.56B | -176.77M | 225.30M | -1.7177 |
Newamsterdam Pharma Company Nv Stock (NAMS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-08-25 | Iniziato | Wells Fargo | Overweight |
| 2025-07-17 | Iniziato | Goldman | Neutral |
| 2025-06-17 | Iniziato | Citigroup | Buy |
| 2025-06-10 | Iniziato | Stifel | Buy |
| 2025-06-04 | Iniziato | Cantor Fitzgerald | Overweight |
| 2024-12-30 | Iniziato | H.C. Wainwright | Buy |
| 2024-05-15 | Iniziato | TD Cowen | Buy |
| 2024-03-14 | Iniziato | Scotiabank | Sector Outperform |
| 2024-01-18 | Iniziato | Guggenheim | Buy |
| 2024-01-16 | Iniziato | Piper Sandler | Overweight |
| 2023-10-30 | Iniziato | RBC Capital Mkts | Outperform |
Mostra tutto
Newamsterdam Pharma Company Nv Borsa (NAMS) Ultime notizie
Is NewAmsterdam Pharma Company N.V. Equity Warrant stock a top pick in earnings seasonMarket Performance Report & High Accuracy Trade Alerts - newser.com
Published on: 2025-10-15 11:31:06 - newser.com
Tools to assess NewAmsterdam Pharma Company N.V.’s risk profileQuarterly Earnings Report & Long Hold Capital Preservation Plans - newser.com
Newamsterdam Pharma stock hits all-time high at 39.76 USD By Investing.com - Investing.com South Africa
Newamsterdam Pharma stock hits all-time high at 39.76 USD - Investing.com India
Can NewAmsterdam Pharma Company N.V. stock resist sector downturnsJuly 2025 Pullbacks & AI Optimized Trading Strategy Guides - newser.com
Is NewAmsterdam Pharma Company N.V. stock a good choice for value investorsTrade Exit Summary & Verified Short-Term Plans - newser.com
NewAmsterdam Pharma Company N.V. recovery potential after sell offJuly 2025 Final Week & Verified Momentum Stock Watchlist - newser.com
Advanced analytics toolkit walkthrough for NewAmsterdam Pharma Company N.V. Equity Warrant2025 Top Gainers & AI Enhanced Execution Alerts - newser.com
Can technical indicators confirm NewAmsterdam Pharma Company N.V. Equity Warrant’s reversalJuly 2025 PreEarnings & Real-Time Volume Surge Alerts - newser.com
NewAmsterdam Pharma Hits New 52-Week High of $39.76, Up 88.77% - Markets Mojo
Using fundamentals and technicals on NewAmsterdam Pharma Company N.V. Equity Warrant2025 Geopolitical Influence & Safe Investment Capital Preservation Plans - newser.com
Caristo Chosen by Leading Pharma Company as Worldwide Imaging Core Lab to Measure Coronary Plaque and Inflammation (2025-10-14) - Seeking Alpha
How to track smart money flows in NewAmsterdam Pharma Company N.V. Equity WarrantPortfolio Performance Summary & Community Driven Trade Alerts - newser.com
Real time alert setup for NewAmsterdam Pharma Company N.V. Equity Warrant performanceJuly 2025 Setups & Step-by-Step Trade Execution Guides - newser.com
Can you recover from losses in NewAmsterdam Pharma Company N.V.Quarterly Risk Review & Weekly Market Pulse Alerts - newser.com
Why NewAmsterdam Pharma Company N.V. Equity Warrant stock attracts global investorsJuly 2025 Short Interest & Weekly Stock Performance Updates - newser.com
Technical analysis overview for NewAmsterdam Pharma Company N.V. Equity Warrant stockMarket Performance Summary & Accurate Trade Setup Notifications - newser.com
Is NewAmsterdam Pharma Company N.V. Equity Warrant forming a bottoming baseEarnings Growth Summary & Low Drawdown Investment Ideas - newser.com
Is it too late to sell NewAmsterdam Pharma Company N.V. Equity WarrantEarnings Beat & High Conviction Buy Zone Picks - newser.com
Will earnings trigger a reversal in NewAmsterdam Pharma Company N.V.Recession Risk & Fast Exit/Entry Strategy Plans - newser.com
Published on: 2025-10-13 07:22:45 - newser.com
Published on: 2025-10-12 22:17:07 - newser.com
What Insider Transactions Reveal About Hindusthan Urban Infrastructure Limiteds OutlookReal-Time Stock Alerts & Free Powerful Profit Generation - earlytimes.in
NewAmsterdam Pharma (NASDAQ:NAMS) Hits New 12-Month HighHere's Why - MarketBeat
NewAmsterdam Pharma (NAMS) Stock Soars on Cholesterol Drug Breakthrough – What Investors Should Know - ts2.tech
NAMS Stock Surge: What Lies Ahead? - timothysykes.com
NewAmsterdam Pharma (NASDAQ:NAMS) Given "Sell (D-)" Rating at Weiss Ratings - MarketBeat
Why NewAmsterdam Pharma (NAMS) Is Up 7.5% After Late-Stage Obicetrapib Trial Optimism - Yahoo Finance
NewAmsterdam Pharma Company N.V. Equity Warrant stock trend forecastMarket Sentiment Review & Weekly High Conviction Trade Ideas - newser.com
Exit strategy if you’re trapped in NewAmsterdam Pharma Company N.V. Equity WarrantEarnings Beat & Reliable Price Breakout Signals - newser.com
Is this a good reentry point in NewAmsterdam Pharma Company N.V.Weekly Stock Analysis & Smart Investment Allocation Insights - newser.com
Custom watchlist performance reports with NewAmsterdam Pharma Company N.V.Weekly Market Report & Daily Technical Forecast Reports - newser.com
NewAmsterdam Pharma Company N.V. stock momentum explainedTrend Reversal & AI Enhanced Execution Alerts - newser.com
Topper, director at NewAmsterdam Pharma, buys $31,487 in shares By Investing.com - Investing.com Nigeria
Knights of Columbus Asset Advisors LLC Invests $595,000 in NewAmsterdam Pharma Company N.V. $NAMS - MarketBeat
NewAmsterdam Pharma Hits New 52-Week High of $34.62 - Markets Mojo
NewAmsterdam Pharma Company N.V. (NAMS) Soars 5.9%: Is Further Upside Left in the Stock? - Nasdaq
NewAmsterdam Pharma (NAMS) Stock Analysis: Uncovering a Promising 25% Upside in Biotechnology - DirectorsTalk Interviews
Newamsterdam Pharma stock hits 52-week high at 31.96 USD By Investing.com - Investing.com Canada
NewAmsterdam Pharma (NASDAQ:NAMS) Stock Price Up 8.8%Here's Why - MarketBeat
NewAmsterdam Pharma Co. Hits New 52-Week High of USD 31.81 - Markets Mojo
Is NewAmsterdam Pharma Company NV a good long term investmentRSI Overbought/Oversold & Exceptional Profit Trading - earlytimes.in
Newamsterdam Pharma stock hits 52-week high at 31.96 USD - Investing.com
Will NewAmsterdam Pharma Company N.V. (KH6) stock beat Nasdaq index returnsQuarterly Earnings Summary & Target Return Focused Stock Picks - newser.com
Institutional scanner results for NewAmsterdam Pharma Company N.V.Portfolio Risk Report & Entry Point Confirmation Alerts - newser.com
How NewAmsterdam Pharma Company N.V. stock performs in weak economyWeekly Stock Summary & Smart Money Movement Alerts - newser.com
Published on: 2025-10-05 03:30:23 - newser.com
Newamsterdam Pharma Company Nv Azioni (NAMS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Newamsterdam Pharma Company Nv Azioni (NAMS) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Kooij Louise Frederika | Chief Accounting Officer |
Sep 09 '25 |
Option Exercise |
10.00 |
150,000 |
1,500,000 |
165,000 |
| Kooij Louise Frederika | Chief Accounting Officer |
Sep 09 '25 |
Sale |
25.83 |
150,000 |
3,874,017 |
15,000 |
| Topper James N | Director |
Sep 08 '25 |
Buy |
24.99 |
1,260 |
31,487 |
3,027,864 |
2.96%
0.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):